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Abstract
Introduction: Lactobacilli are currently proposed as probiotic agents in several dietary products.
In blood cultures, they are usually considered as contaminants, but in recent years they have been
recognized as causal infectious agents of endocarditis, urinary tract infections, meningitis, intra-
abdominal infections and bacteraemia.
Case presentation: We report a case of Lactobacillus casei bacteraemia in a 66-year-old
immunocompetent man with a history of fever of unknown origin. Leuconostoc bacteraemia was
demonstrated by blood culture, but a later polymerase chain reaction analysis with sequencing of
16S ribosomal RNA identified Lactobacillus casei and a successful antibiotic therapy was performed.
Conclusion: Bacteraemia caused by probiotic organisms is rare but underestimated, since they
are normally regarded as contaminants and their role as primary invaders is not always easily
established. Although the consumption of probiotic products cannot be considered a risk factor in
the development of diseases caused by usually non-pathogenic bacteria, specific individual clinical
histories should be taken into account. This report should alert both clinicians and microbiologists
to the possibility of unusual pathogens causing serious illnesses and to the use of 16S ribosomal
RNA sequencing for molecular identification as a powerful tool in confirming the diagnosis of
infrequent pathogens.
Introduction
Bacteraemia due to lactobacilli is uncommon among
immunocompetent patients. One of the current limita-
tions in the laboratory processing of blood cultures is the
requirement to subculture isolates in order to perform fur-
ther testing necessary for bacterial identification. This
often results in one or more days of delay in the aetiolog-
ical diagnosis and errors in identification can occur [1].
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humans, they colonize the oral cavity, gastrointestinal
tract, and vagina. In general, lactobacilli have little or no
virulence, but have been recognized as opportunistic
pathogens in some reports [2-9]. The clinical significance
of Lactobacillus bacteraemia in immunocompetent
patients is not clear, but considering the wide distribution
of Lactobacillus and the relatively few infections they cause,
these bacteria can be considered to have very little viru-
lence in healthy humans.
Case presentation
A 66-year-old man was referred to the Haematological
and Transfusional Medicine Department of an urban gen-
eral hospital in December for persistent fever and night
sweating. The patient was affected by hypertension, diver-
ticulosis, haemorrhoidal bleeding and by chronic obstruc-
tive pulmonary disease with periodic exacerbations.
Starting in June, the patient reported weakness, increased
blood glucose serum levels and decreased body weight. In
November, swelling of superficial lymph nodes, fever and
nocturnal sweating had occurred. The laboratory test
results showed normocytic normochromic anaemia (hae-
moglobin, Hb, 9.5 g/dl), white blood cell count (WBC)
was 7170/mm3 with 85% neutrophils and 11% lym-
phocytes, 7.13 mg/dl C-reactive protein (CRP) with nor-
mal values < 0.8 mg/dl, erythrocyte sedimentation rate
(ESR) of 59 mm/hour, fibrinogen 597 mg/dl (normal
range 150–450) and beta 2-microglobulin 5.21 mg/litre
(normal values 1.42–3.21 mg/litre). Levels of Ca 15.3, Ca
19.9, PSA, TPA, alpha-fetoprotein, FT3, FT4, TSH, vitamin
B12 and folic acid were in the normal range. Serological
tests for CMV, Toxoplasma gondii, VZV, Brucella, HBV, HCV
and HIV were negative. The Tuberculin Sensitivity Test
with 5 IU of Purified Protein Derivative (PPD) was per-
formed with negative results. Markers for autoimmune
diseases (ANA, APCA, ASMA, and ENA) were in the nor-
mal range.
In December, because of persistent fever, weakness, noc-
turnal sweating and loss of 7 kg in body weight, the
patient was referred to the Haematological Department.
Blood examinations documented a persistent increase in
ESR (90 mm/hour) and CRP (6.7 mg/dl) levels and a pro-
gressive haemoglobin decrease (nadir 8 g/dl); dosage of
cytokines showed increased levels of IL-6 (12.7 pg/ml,
normal values < 4.1), IL-10 (20.5 pg/ml, normal values <
9.1) and TNF-alpha (32.4 pg/ml, normal values < 8.1);
the study of B- and T-lymphocyte subpopulations by RT-
PCR (CD5, CD19, CD20, Sig, CD3, CD7, TCR) gave nor-
mal results. Blood transfusions and iron therapy were per-
formed. In January, total body computed tomography
(CT) scanning showed cardio- and splenomegaly. Non-
complicated diverticulosis in the descending colon and
sigmoid colon and anal haemorrhoids were revealed by
colonoscopy. A trans-oesophageal echocardiogram
showed mitral prolapse with regurgitation but no valvular
vegetation was found. A dental X-ray was negative for den-
tal abscess or caries.
In February, the patient was referred to the Infectious Dis-
ease Department. On admission, four consecutive blood
cultures were performed. Gram-positive aerobic-anaero-
bic coccobacillary bacteria were isolated from all speci-
mens and identified as Leuconostoc spp. resistant to
vancomycin and trimethoprim-sulphamethoxazole. Ther-
apy with parenteral levofloxacin (500 mg intravenous
bid) was started. After 2 weeks of parenteral therapy, the
patient's conditions improved, but because of persistence
of fever and increased levels of ESR (59 mm/hour), the
therapy was continued with oral moxifloxacin. A blood
culture specimen was examined with PCR for sequencing
of 16S ribosomal RNA. The molecular analysis did not
confirm the previous diagnosis and the microorganism
was identified as Lactobacillus casei.
In March, haemorrhoidectomy was performed. During
the postoperative period, the patient developed respira-
tory failure with an increased ESR (100 mm/hour). Chest
CT scanning revealed multifocal pneumonia. Blood and
sputum culture results were negative. A 7-day course of
parenteral therapy with amoxicillin-clavulanate (2 g bid)
was added to the moxifloxacin. In April, after 6 weeks of
fluoroquinolone therapy, the patient was feeling well:
fever, weakness and nocturnal sweating had resolved, the
haemoglobin and CRP serum levels were in the normal
range, ESR was reduced (51 mm/hour) and antimicrobial
therapy was stopped.
Three months after the end of antibiotic therapy, the
patient was hospitalized because of a new episode of
multifocal pneumonia, likely to be secondary to a previ-
ous upper respiratory tract infection. During the hospital-
ization, an abdomen CT scan demonstrated
normalization of spleen size. A trans-thoracic echocardio-
gram confirmed the presence of cardiomegaly and mitral
prolapse with regurgitation. Blood and sputum cultures
were negative. The patient was successfully treated with
intravenous ampicillin-sulbactam (2/1 g tid) and oral lev-
ofloxacin (500 mg qd). No microorganisms were isolated
in blood, sputum or urine.
Six months after the bloodstream infection with Lactoba-
cillus casei, the patient reported a marked increase in body
weight with complete normalization of ESR (8 mm/
hour), CRP (0.5 mg/dl), and Hb values (13 g/dl). Now the
patient is on the waiting list for cardiac valvular replace-
ment.Page 2 of 4
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Bacteraemia results in significant morbidity and mortal-
ity, especially among immunocompromised patients, but
it is uncommon among immunocompetent people with-
out risk factors for bloodstream infections [1].
Lactobacilli are Gram-positive, catalase-negative, non-
sporulating, aerobic or facultative anaerobic, rod-shaped
bacteria. They are ubiquitous and inhabit a wide variety of
habitats, including the gastrointestinal tract, oral cavity
and vagina. Moreover, these bacteria are traditionally used
in the manufacture of fermented foods and as probiotic
[2].
Among pathogenic species in humans, Lactobacillus casei
appears to be the most frequently isolated, although L.
paracasei and L. rhamnosus are also encountered in clinical
situations [2]. However, isolates are often only identified
by genus and the most automated identification systems
are not capable of accurate differentiation of Lactobacillus
species. These microorganisms are rarely infectious and
their presence as commensals in the gastrointestinal tract
is associated with protection against pathogens, stimula-
tion of the immune system and positive effects on colonic
health and host nutrition.
Although lactobacilli are usually considered contami-
nants in blood cultures, they have been identified in some
clinical reports as causal agents of dental caries, infectious
endocarditis, urinary tract infections, chorioamnionitis,
endometritis, meningitis, intra-abdominal, liver or spleen
abscesses, and bacteraemia [2-7]. Commonly, these infec-
tions can be correlated with previous illnesses (recent sur-
gery, transplants, valvulopathy, diabetes mellitus, AIDS
and cancer) or with either immunosuppressive therapy or
antibiotic treatment, which could promote the develop-
ment or the selection of the microorganism.
Leuconostoc are Gram-positive, non-motile, aerobic-anaer-
obic facultative, coccobacillary bacteria members of the
Streptococcaceae family, environmental organisms com-
monly found in vegetable matter, in milk products and
other chilled food products. These pathogens can often be
mistaken by automated identification systems that are not
capable of accurate differentiation.
In our report, a temporal correlation was reported
between consumption of probiotic lactobacilli and
bacteraemia in the presence of intestinal disease. Because
of the previous diagnosis of diverticulosis, the patient had
frequently eaten probiotic dietary products with Lactoba-
cillus casei before the onset of fever. Recently, reports have
increased of Lactobacillus infections after probiotic lacto-
bacilli intake, particularly in the paediatric populations
with underlying diseases, for example in short-gut syn-
drome [8,9]. In our patient, underlying diseases such as
endocarditis, abscess, neoplasia or chronic bowel disease
were excluded. Nevertheless, in some reports, diverticulo-
sis was reported as the cause of bacteraemia in immuno-
competent people [10]. In our patient, it is possible that
intestinal diverticulosis, with local mucositis, could repre-
sent the intestinal entry site of the Lactobacillus casei in the
bloodstream. The determination of faecal calprotectin, a
biomarker of altered intestinal permeability state, has not
been performed and without data on the calprotectin
level, no major consideration can be raised on the role
played by increased permeability states [11].
Bacteraemia caused by probiotic organisms is rare but
underestimated, since they are normally regarded as con-
taminants and their role as primary invaders is not always
easily established. Although the increased consumption
of dairy products does not appear to promote an increase
in Lactobacillus sp. bacteraemia, it is noteworthy that the
probiotic strain of Lactobacillus rhamnosus has been
involved in several bacteraemia cases and Lactobacillus
populations can survive in the gastrointestinal tract of
humans after oral administration [8].
The identification of unusual disease agents by conven-
tional methods involves some degree of subjective evalu-
ation and the conventional procedures used in most
Italian hospitals are not specifically designed for it. As the
16S ribosomal RNA nucleotide sequence is available in
databases for most bacterial species, 16S ribosomal RNA
sequencing becomes a valuable identification strategy for
such microorganisms [12].
Conclusion
This report of a case of Lactobacillus casei bacteraemia in an
immunocompetent individual should alert both clini-
cians and microbiologists to the possibility of unusual
pathogens causing serious illnesses; also, 16S ribosomal
RNA molecular identification seems to represent a power-
ful tool in the confirmation of diagnosis of infrequent
pathogens.
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